Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase

Human Gene Therapy

Volumn 17, Issue 9, 2006, Pages 898-908

  Machado, Alexandre V ^a,b   Cardoso, Jarbas E ^a   Claser, Carla ^c   Rodrigues, Mauricio M ^c   Gazzinelli, Ricardo T ^a,b   Bruna Romero, Oscar ^a,b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; AMASTIGOTE SURFACE PROTEIN 2; BETA GALACTOSIDASE; GAMMA INTERFERON; MEMBRANE PROTEIN; PARASITE ANTIGEN; SIALIDASE; TRANS SIALIDASE; UNCLASSIFIED DRUG; ASP 2 PROTEIN, TRYPANOSOMA CRUZI; ASP-2 PROTEIN, TRYPANOSOMA CRUZI; GLYCOPROTEIN; PROTOZOAL VACCINE; TRANS-SIALIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHAGAS DISEASE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG SCREENING; GENETIC ENGINEERING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOTHERAPY; MOUSE; NONHUMAN; T LYMPHOCYTE ACTIVATION; TH1 CELL; TRYPANOSOMA CRUZI; VACCINATION; VIRUS RECOMBINANT; ADENOVIRUS; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC RECOMBINATION; GENETICS; IMMUNOLOGY; MOUSE MUTANT; MOUSE STRAIN; TRYPANOSOMIASIS;

ANIMALIA; MUS; PROTOZOA; TRYPANOSOMA CRUZI;

ADENOVIRIDAE; AMINO ACID SEQUENCE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; NEURAMINIDASE; PROTOZOAN VACCINES; RECOMBINATION, GENETIC; TH1 CELLS; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

EID: 33750627515     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.17.898     Document Type: Article

References (41)

1. BASOMBRIO, M.A. (1990). Trypanosoma cruzi: Partial prevention of the natural infection of guinea pigs with a killed parasite vaccine. Exp. Parasitol. 71, 1-8.
2. BOSCARDIN, S.B., KINOSHITA, S.S., FUJIMURA, A.E., and RODRIGUES, M.M. (2003). Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection. Infect. Immun. 71, 2744-2757.
3. BRENER, Z., and GAZZINELLI, R.T. (1997). Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int. Arch. Allergy Immunol. 114, 103-110.
4. BRUNA-ROMERO, O., LASARTE, J.J., WILKINSON, G., GRACE, K., CLARKE, B., BORRAS-CUESTA, F., and PRIETO, J. (1997). Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus. Hepatology 25, 470-477.
5. BRUNA-ROMERO, O., GONZALEZ-ASEGUINOLAZA, G., HAFALLA, J.C., TSUJI, M., and NUSSENZWEIG, R.S. (2001). Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen. Proc. Natl. Acad. Sci. U.S.A. 98, 11491-11496.
6. BRUNA-ROMERO, O., ROCHA, C.D., TSUJI, M., and GAZZINELL, R.T. (2004). Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif. Vaccine 22, 3575-3584.
7. CAMANDAROBA, E.L., REIS, E.A., GONCALVES, M.S., REIS, M.G., and ANDRADE, S.G. (2003). Trypanosoma cruzi: Susceptibility to chemotherapy with benznidazole of clones isolated from the highly resistant Colombian strain. Rev. Soc. Bras. Med. Trop. 36, 201-209.
8. CARVALHO, C.M., ANDRADE, M.C., XAVIER, S.S., MANGIA, R.H., BRITTO, C.C., JANSEN, A.M., FERNANDES, O., LANNES-VIEIRA, J., and BONECINI-ALMEIDA, M.G. (2003). Chronic Chagas' disease in rhesus monkeys (Macaca mulatta): Evaluation of parasitemia, serology, electrocardiography, echocardiography, and radiology. Am. J. Trop. Med. Hyg. 68, 683-691.
9. COSTA, F., FRANCHIN, G., PEREIRA-CHIOCCOLA, V.L., RIBEIRAOM, M., SCHENKMAN, S., and RODRIGUES, M.M. (1998). Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Vaccine 16, 768-774.
10. DENKERS, E.Y., and GAZZINELLI, R.T. (1998). Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin. Microbiol. Rev. 11, 569-588.
11. DUMONTEIL, E., ESCOBEDO-ORTEGON, J., REYES-RODRIGUEZ, N., ARJONA-TORRES, A., and RAMIREZ-SIERRA, M.J. (2004). Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice. Infect. Immun. 72, 46-53.
12. FRALISH, B.H., and TARLETON, R.L. (2003). Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection. Vaccine 21, 3070-3080.
13. + T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene. Infect. Immun. 69, 5477-5486.
14. GARG, N., and TARLETON, R.L. (2002). Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect. Immun. 70, 5547-5555.
15. GUILLOT, L., LE GOFFIC, R., BLOCH, S., ESCRIOU, N., AKIRA, S., CHIGNARD, M., and SI-TAHAR, M. (2005). Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280, 5571-5580.
16. HOFT, D.F., and EICKHOFF, C.S. (2005). Type 1 immunity provides both optimal mucosal and systemic protection against a mucosally invasive, intracellular pathogen. Infect. Immun. 73, 4934-4940.
17. + Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi. Infect. Immun. 68, 197-204.
18. HOLSCHER, C., KOHLER, G., MULLER, U., MOSSMAN, H., SHAUB, G.A., and BROMBACHER, F. (1998). Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in γ interferon receptor or inducible nitric oxide synthase. Infect. Immun. 66, 1208-1215.
19. KRETTLI, A.U., and BRENER, Z. (1976). Protective effects of specific antibodies in Trypanosoma cruzi infections. J. Immunol. 116, 755-760.
20. + CTL. J. Immunol. 160, 1817-1823.
21. + T cells in Trypanosoma cruzi infection. Immunol. Rev. 201, 304-317.
22. MENEZES, H. (1968). Active immunization of mice with the avirulent Y strain of Trypanosoma cruzi against experimental infection of mice. Rev. Inst. Med. Trop. Sao Paulo 10, 1-4.
23. + T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection. Infect. Immun. 73, 7356-7365.
24. MOLINIER-FRENKEL, V., PREVOST-BLONDEL, A., HONG, S.S., LENGAGNE, R., BOUDALY, S., MAGNUSSON, M.K., BOULANGER, P., and GUILLET, J.G. (2003). The maturation of murine dendritic cells induced by human adenovirus is mediated by the fiber knob domain. J. Biol. Chem. 278, 37175-37182.
25. NICKELL, S.P., and SHARMA, D. (2000). Trypanosoma cruzi: Roles for perforin-dependent and perforin independent immune mechanisms in acute resistance. Exp. Parasitol. 94, 207-216.
26. OEHEN, S., and BRDUSCHA-RIEM, K. (1998). Differentiation of naive CTL to effector and memory CTL: Correlation of effector function with phenotype and cell division. J. Immunol. 161, 5338-5346.
27. PINGE-FILHO, P., PERON, J.P., DE MOURA, T.R., MENOLLI, R.A., GRACA, V.K., ESTEVAO, D., TADOKORO, C.E., JANKEVICIUS, J.V., and RIZZO, L.V. (2005). Protective immunity against Trypanosoma cruzi provided by oral immunization with Phytomonas serpens: Role of nitric oxide. Immunol. Lett. 96, 283-290.
28. RIBEIRAO, M., PEREIRA CHIOCCOLA, V.L., EICHINGER, D., RODRIGUES, M.M., and SCHENKMAN, S. (1997). Temperature differences for trans-glycosylation and hydrolysis reaction reveal an acceptor binding site in the catalytic mechanism of Trypanosoma cruzi trans-sialidase. Glycobiology 7, 1237-1246.
29. ROCHA, C., CAETANO, B., MACHADO, A., and BRUNA-ROMERO, O. (2004). Recombinant viruses as tools to induce protective cellular immunity against infectious diseases. Int. Microbiol. 7, 89-94.
30. RODRIGUES, M.M., RIBEIRAO, M., PEREIRA-CHIOCCOLA, V., RENIA, L., and COSTA, F. (1999). Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene. Infect. Immun. 67, 3855-3863.
31. RODRIGUES, M.M., BOSCARDIN, S.B., VASCONCELOS, J.R., HIYANE, M.I., SALAY, G., and SOARES, I.S. (2003). Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccines. Ann. Braz. Acad. Sci. 75, 443-468.
32. SCHENKMAN, S., EICHINGER, D., PEREIRA, M.E., and NUSSENZWEIG, V. (1994). Structural and functional properties of Trypanosoma trans-sialidase. Annu. Rev. Microbiol. 48, 499-523.
33. SCHNAPP, A.R., EICKHOFF, C.S., SCHARFSTEIN, J., and HOFT, D.F. (2002). Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection. Microbes Infect. 4, 805-813.
34. SEPULVEDA, P., HONTEBEYRIE, M., LIEGEARD, P., MASCILLI, A., and NORRIS, K.A. (2000). DNA-based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection. Infect. Immun. 68, 4986-4991.
35. SHAW, G., MORSE, S., ARARAT, M., and GRAHAM, F.L. (2002). Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 16, 869-871.
36. SHIVER, J.W., FU, T.M., CHEN, L., CASIMIRO, D.R., DAVIES, M.E., EVANS, R.K., ZHANG, Z.Q., SIMON, A.J., TRIGONA, W.L., DUBEY, S.A., HUANG, L., HARRIS, V.A., LONG, R.S., LIANG, X., HANDT, L., SCHLEIF, W.A., ZHU, L., FREED, D.C., PERSAUD, N.V., GUAN, L., PUNT, K.S., TANG, A., CHEN, M., WILSON, K.A., COLLINS, K.B., HEIDECKER, G.J., FERNANDEZ, V.R., PERRY, H.C., JOYCE, J.G., GRIMM, K.M., COOK, J.C., KELLER, P.M., KRESOCK, D.S., MACH, H., TROUTMAN, R.D., ISOPI, L.A., WILLIAMS, D.M., XU, Z., BOHANNON, K.E., VOLKIN, D.B., MONTEFIORI, D.C., MIURA, A., KRIVULKA, G.R., LIFTON, M.A., KURODA, M.J., SCHMITZ, I.E., LETVIN, N.L., CAULFIELD, M.J., BETT, A.J., YOUIL, R., KASLOW, D.C., and EMINI, E.A. (2002). Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415, 331-335.
37. TATSIS, N., and ERTL, H.C. (2004). Adenoviruses as vaccine vectors. Mol. Ther. 10, 616-629.
38. URBINA, J.A. (2001). Specific treatment of Chagas disease: Current status and new developments. Curr. Opin. Infect. Dis. 14, 733-741.
39. VASCONCELOS, J.R., HIYANE, M.I., MARINHO, C.R., CLASER, C., MACHADO, A.M., GAZZINELLl, R.T., BRUNA-ROMERO, O., ALVAREZ, J.M., BOSCARDIN, S.B., and RODRIGUES, M.M. (2004). Protective immunity against Trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and tras-sialidase. Hum. Gene Ther. 15, 878-886.
40. WANG, L., GOSCHNICK, M.W., and COPPEL, R.L. (2004). Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge. Infect. Immun. 72, 6172-6175.
41. ZAPATA-ESTRELLA, H., HUMMEL-NEWELL, C., SANCHEZ-BURGOS, G., ESCOBEDO-ORTEGON, J., RAMIREZ-SIERRA, M.J., ARJONA-TORRES, A., and DUMONTEIL. E. (2006). Control of Trypanosoma cruzi infection and changes in T-cell populations induced by a therapeutic DNA vaccine in mice. Immunol. Lett. 103, 186-191.